We at Rare Disease Report are looking forward to attending the American Academy of Neurology (AAN) 2016 Annual Meeting in Vancouver BC this year and reporting back daily with highlights from the conference.
Some of the topics we are eager to learn more about include:
New enzyme replacement therapy in development to treat late-onset Pompe disease
Duchenne muscular dystrophy updates for eteplirsen, ataluren, deflazacort, etc
Details of the latest developments to manage neuromyelitis optica
Efficacy of Banzel to treat Lennox-Gastaut Syndrome
Afinitor – is it even better than first thought for tuberous sclerosis complex?
Stiff person syndrome – how common is it?
The latest on Abobotulinum toxin A
Treatment options in development for super-refractory status epilepticus
Zika virus and neuropathology
NFL players and brain damage
And much much more.
Look for our daily updates during the conference. It is going to be an exciting time with so many new orphan drugs being tested and long term data presented.